Clinical trial
Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7…
NCT01911975 · Academisch Ziekenhuis Maastricht, Other · Completed
Key facts
| NCT number | NCT01911975 |
|---|---|
| Title | Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber Neuropathy |
| Official title | Efficacy, Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber Neuropathy: a Randomized, Double-blind, Placebo Controlled, Crossover Trial |
| Lead sponsor | Academisch Ziekenhuis Maastricht, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Small Fiber Neuropathy |
| Intervention type | Drug |
| Interventions | Lacosamide, Placebo |
| Enrollment | 25 |
| Start date | Sep 1, 2014 |
| Primary completion | May 1, 2017 |
| Completion | May 1, 2017 |
| First posted | Jul 30, 2013 |
| Last update posted | Jan 10, 2018 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: